Catalyst
Slingshot members are tracking this event:
Pacira (PCRX) to Initiate Phase 4 Study in Q4 Evaluating EXPAREL in Pain Related to Breast Reconstruction
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PCRX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 17, 2019
Occurred Source:
https://www.nasdaq.com/article/paciras-study-on-exparel-label-expansion-meets-endpoints-cm1083846
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Exparel, Phase 4, Pain, Breast Reconstruction, Trial Initiation
